Navigation Links
Emdeon Assistant Earns HFMA Peer Reviewed Certification for Second Year in a Row
Date:6/15/2009

Scores Are Higher Following Review of Performance Indicators

NASHVILLE, Tenn., June 15 /PRNewswire/ -- Emdeon, a leader in revenue and payment cycle solutions, announced today that their automated patient eligibility and benefits verification tool, Emdeon(R) Assistant(TM), earned the Peer Reviewed designation of the Healthcare Financial Management Association (HFMA) for the second consecutive year. HFMA Peer Review designation places Emdeon Assistant on a short list of prestigious solutions that have been proven effective by industry expert volunteers and independent HFMA staff.

All products presented for this certification must meet predetermined standards as established by HFMA in areas such as product effectiveness, quality, overall value and customer support to earn the Peer Reviewed designation. The 2009 assessment of Emdeon Assistant had an increase in scores for the predetermined standards over the previous year.

Emdeon Assistant simplifies patient registration through real-time eligibility and benefit verifications and interfaces with most existing patient registration systems. By accessing a wide range of information from available payers and credit bureaus, Emdeon Assistant helps providers determine a patient's eligibility status and ability to pay in an easy-to-read format. Emdeon Assistant also verifies patients' addresses and key demographic information, thus helping providers maintain contact with patients after they leave the office for follow-up care, billing or other communications.

In addition, Emdeon Assistant is introducing a new capability to estimate a patient's financial responsibility at the point of service. This information, together with the other data available through Emdeon Assistant, will help customers reduce costly write-offs and errors.

"Our goal is to make healthcare more efficient, and that includes creating tools that help our customers do their jobs more easily and effectively," said George Lazenby, chief executive officer of Emdeon. "We are delighted to receive Peer Reviewed status from HFMA for the second year in a row. This designation is another example of our commitment to offer superior solutions in the healthcare marketplace."

About Emdeon

Emdeon is a leading provider of revenue and payment cycle solutions that connect payers, providers and patients to integrate and automate key business and administrative functions throughout the patient encounter. Through the use of Emdeon's comprehensive suite of products and services, its customers are able to improve efficiency, reduce costs, increase cash flow and more efficiently manage the complex revenue and payment cycle process. Emdeon is owned by General Atlantic LLC and Hellman & Friedman LLC. For more information, visit www.emdeon.com.


'/>"/>
SOURCE Emdeon
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Emdeon Business Services Extends Market Leadership With New Dental Eligibility Payers
2. HLTH Corporation Sells its Minority Interest in Emdeon Business Services to General Atlantic and Hellman & Friedman for $575 Million
3. General Atlantic and Hellman & Friedman Purchase HLTH Corporations Remaining Interest in Emdeon
4. Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy
5. Emdeon Business Services Processes One Billionth Pharmacy Claim for Department of Defense and the U.S. Military Health System
6. Emdeon Assistant Earns HFMAs Peer Review Designation
7. Nashvilles Emdeon Business Services to Co-Sponsor Democratic National Convention Health Policy Event
8. Emdeon Selected by the Maryland Hospital Association to Power the Maryland Transaction Data Interchange
9. Emdeon Convenes Industry Forum to Monitor Business Efficiency in Healthcare
10. Emdeon Announces Agreement to Acquire The Sentinel Group, a Leader in Healthcare Fraud and Abuse Management Services
11. USAID Assistant Administrator Hess Travels to Southern Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... announce that their Vice President of Franchise Development, Paula Turner Pizarro, was recently ... business program, which features the insights of top business leaders from across the ...
(Date:1/18/2017)... ... January 18, 2017 , ... ... solutions for drugs, biologics and consumer health products, today announced that Mr. Michael ... the upcoming WCBP Conference, to be held at the Mayflower Hotel, Washington DC, ...
(Date:1/18/2017)... ... ... Floundering on New Year’s resolutions? Need an excuse to get back on ... U.S. Apple Association agrees and recommends starting each day with apples, a habit ... disease. , The U.S. Apple Association – which represents apple growers and producers nationwide ...
(Date:1/17/2017)... ... ... For breast cancer clinicians and researchers who were unable to attend the ... review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual Best ... February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO from ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate ... Music Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center ... been the gold standard for high-definition, in-ear earphones. This classic earphone has been ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... and innovative products to treat a variety of ... its lead compound DMT210, in a Phase 2 ... specifically developed to downregulate the proinflammatory cytokines in ... seen in acne rosacea. This ...
(Date:1/18/2017)... January 18, 2017 The report " Automated Breast Ultrasound ... Volume Scanner), By End User (Hospitals, Diagnostic Imaging Centers), Industry Analysis Report, Regional ... Argentina , Germany , UK, France ... Russia , China , Japan ... Thailand , Saudi Arabia , UAE, South ...
(Date:1/18/2017)... , Jan. 18, 2017  Tarix Orphan LLC ... has granted a Rare Pediatric Disease (RPD) designation for ... Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare genetic skin ... and treatment is limited to supportive care. ... Orphan Drug Designation previously granted by the FDA in ...
Breaking Medicine Technology: